Drawing for HOVIONE

USPTO serial 79180372

HOVIONE

Reviewed by CopyMark Law Group

Reg. 5248080Status 739Renewal
Filing date
Status date
Registration date
Jul 25, 2017
Examiner
DESAI, BRIN ANDERSON
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with HOVIONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mainak H. Mehta

Mainak H. Mehta Procopio Cory Hargreaves & Savitch525 B Street, Suite 2200San Diego, CA 92101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutically active ingredients and intermediates sold as a component ingredient of pharmaceutical preparations, and pharmaceutical preparations and compounds, all of the foregoing for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animalsACTIVE—
010Medical devices for use in treating conditions and disorders of the respiratory system; Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systemsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 25, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Oct 16, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 26, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 5, 2024NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Apr 5, 2024C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Apr 1, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 22, 2023ES75TEAS SECTION 71 & 15 RECEIVED—
Sep 18, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 25, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 14, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 13, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 24, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 3, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 3, 2017FIMPFINAL DISPOSITION PROCESSED—
Oct 25, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 25, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 23, 2017OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 7, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 7, 2017OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 9, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 9, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 5, 2017GPNXNOTIFICATION PROCESSED BY IB—
Apr 19, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 19, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 19, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 27, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 27, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 22, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 22, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 26, 2016CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 26, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 30, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 29, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 29, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 19, 2016RFNTREFUSAL PROCESSED BY IB—
Feb 29, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 29, 2016RFRRREFUSAL PROCESSED BY MPU—
Feb 27, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 26, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 18, 2016DOCKASSIGNED TO EXAMINER—
Jan 15, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 11, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 7, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance